Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001250853-17-000073

Options or other derivatives

  • Chief Financial Officer acquired 250,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

MORRIS TIMOTHY E · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-08-14 Grant or award : show line 1 in the form Stock Option (right to buy) +250,000 $5.05 2027-08-13 250,000 250,000 D
Loading xslF345X03/primary_doc.xml…